AtriCure, Inc. (ATRC) Posts Q1 EPS Loss of $0.08
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $43.49 -0.16%
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
AtriCure, Inc. (NASDAQ: ATRC) reported Q1 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $15.6 million versus the consensus estimate of $15.96 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
